162 related articles for article (PubMed ID: 15229767)
1. Massive intracavitary clot formation during cardiopulmonary bypass.
Legare JF; Arora R; Wood JW
Can J Cardiol; 2004 Jun; 20(8):825-6. PubMed ID: 15229767
[TBL] [Abstract][Full Text] [Related]
2. [Giant intracavitary thrombi secondary to a heparin-induced thrombocytopenia-thrombosis syndrome].
Fernández Ratero JA; Ayuela Azcárate JM; Fernández de Almeida CA; Aldea Martínez J; Fernández Fernández JL; Zabalegui Pérez A
Rev Esp Cardiol; 1999 Apr; 52(4):269-72. PubMed ID: 10217969
[TBL] [Abstract][Full Text] [Related]
3. Recognition, diagnosis, and management of heparin-induced thrombocytopenia and thrombosis.
Smoot EC; Marx A; Weiman D; Deitcher SR
Plast Reconstr Surg; 1999 Feb; 103(2):559-65. PubMed ID: 9950545
[TBL] [Abstract][Full Text] [Related]
4. Case 5--1996. Thrombosis after the use of a heparin-coated cardiopulmonary bypass circuit in a patient with heparin-induced thrombocytopenia.
Van Dyck MJ; Lavenne-Pardonge E; Azerad MA; Matta AG; Moriau M; Comunale ME
J Cardiothorac Vasc Anesth; 1996 Oct; 10(6):809-15. PubMed ID: 8910165
[No Abstract] [Full Text] [Related]
5. Heart transplantation in patients with heparin-induced thrombocytopenia on the Novacor left ventricular assist system.
Brozena SC; Twomey C; Siegel J; Peterson P; Horrow JC; Samuels L; Morris R
J Heart Lung Transplant; 1998 Jul; 17(7):729-31. PubMed ID: 9703240
[TBL] [Abstract][Full Text] [Related]
6. A fatal complication after repair of post-infarction ventricular septal rupture: heparin-induced thrombocytopenia with thrombosis.
Nazli Y; Colak N; Demircelik B; Alpay MF; Cakir O; Cagli K
Cardiovasc J Afr; 2015 May; 26(3):e11-5. PubMed ID: 26592990
[TBL] [Abstract][Full Text] [Related]
7. Successful surgical management of massive pulmonary embolism during the second trimester in a parturient with heparin-induced thrombocytopenia.
Hajj-Chahine J; Jayle C; Tomasi J; Corbi P
Interact Cardiovasc Thorac Surg; 2010 Nov; 11(5):679-81. PubMed ID: 20729238
[TBL] [Abstract][Full Text] [Related]
8. Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis.
Follis F; Schmidt CA
Ann Thorac Surg; 2000 Dec; 70(6):2173-81. PubMed ID: 11156153
[TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopenia and thrombosis syndrome after cardiopulmonary bypass.
Holmes-Ghosh E
Am J Crit Care; 2000 Jul; 9(4):276-8. PubMed ID: 10888150
[No Abstract] [Full Text] [Related]
10. Left ventricular thrombus during cardiopulmonary bypass as the primary manifestation of heparin-induced thrombocytopenia.
Ploppa A; Haeberle L; Schmid E; Nohe B
J Cardiothorac Vasc Anesth; 2013 Aug; 27(4):744-8. PubMed ID: 22236793
[No Abstract] [Full Text] [Related]
11. Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial.
Koster A; Dyke CM; Aldea G; Smedira NG; McCarthy HL; Aronson S; Hetzer R; Avery E; Spiess B; Lincoff AM
Ann Thorac Surg; 2007 Feb; 83(2):572-7. PubMed ID: 17257990
[TBL] [Abstract][Full Text] [Related]
12. Heparin-induced thrombocytopenia type II in an infant with a congenital heart defect--anticoagulation during cardiopulmonary bypass with epoprostenol sodium and heparin.
von Heymann C; Hagemeyer E; Kastrup M; Ziemer S; Proquitté H; Konertz WF; Spies C
Pediatr Crit Care Med; 2006 Jul; 7(4):383-5. PubMed ID: 16738494
[TBL] [Abstract][Full Text] [Related]
13. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK
J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571
[TBL] [Abstract][Full Text] [Related]
14. Heparin-bonded circuit with low systemic anticoagulation in a patient with heparin-induced thrombocytopenia: a case report.
O'Gara PJ; Aldea GS; Shemin RJ; Shapira OM
J Extra Corpor Technol; 1999 Sep; 31(3):142-4. PubMed ID: 10847957
[TBL] [Abstract][Full Text] [Related]
15. Report: Heparin-induced thrombocytopenia associated with cardiopulmonary bypass: Preliminary attempt with recombinant human thrombopoietin therapy.
Yuan SM
Pak J Pharm Sci; 2015 Sep; 28(5):1793-6. PubMed ID: 26408899
[TBL] [Abstract][Full Text] [Related]
16. [Fatal central pulmonary embolism under heparin therapy: white-clot syndrome].
Canova CR; Cantieni R; Zellweger U; Reinhart WH
Schweiz Med Wochenschr; 1997 May; 127(18):762-5. PubMed ID: 9221488
[TBL] [Abstract][Full Text] [Related]
17. Recurrent left atrial and left ventricular thrombosis due to heparin-induced thrombocytopenia: case report and short review.
Kuhl T; Wendt S; Langebartels G; Kröner A; Wahlers T
Thorac Cardiovasc Surg; 2013 Sep; 61(6):537-40. PubMed ID: 23424064
[TBL] [Abstract][Full Text] [Related]
18. [Heparin as the cause of severe thrombosis].
Abildgaard U; Myhre HO
Tidsskr Nor Laegeforen; 1996 Feb; 116(6):757-8. PubMed ID: 8644082
[TBL] [Abstract][Full Text] [Related]
19. Con: heparin is not the best anticoagulant for cardiopulmonary bypass.
Fitch JC
J Cardiothorac Vasc Anesth; 1996 Oct; 10(6):819-21. PubMed ID: 8910167
[No Abstract] [Full Text] [Related]
20. Acute left main occlusion during percutaneous coronary intervention associated with heparin induced thrombocytopenia with thrombosis syndrome.
Ziakas A; Gavrilidis S; Makris P; Louridas G
J Interv Cardiol; 2005 Apr; 18(2):139-44. PubMed ID: 15882162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
